Concurrent Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Buy
30,331
+8,491
+39% +$654K 0.02% 585
2025
Q4
$1.73M Buy
21,840
+3,865
+22% +$305K 0.02% 621
2025
Q3
$1.36M Buy
17,975
+1,782
+11% +$122K 0.02% 569
2025
Q2
$1.12M Buy
16,193
+2,771
+21% +$182K 0.02% 568
2025
Q1
$909K Sell
13,422
-33,826
-72% -$2.02M 0.02% 571
2024
Q4
$2.12M Sell
47,248
-13,563
-22% -$761K 0.06% 311
2024
Q3
$3.82M Sell
60,811
-1,075
-2% -$62.7K 0.11% 188
2024
Q2
$3.66M Buy
61,886
+43,518
+237% +$2.72M 0.12% 176
2024
Q1
$1.46M Buy
18,368
+296
+2% +$22.6K 0.06% 299
2023
Q4
$1.43M Buy
+18,072
New +$1.29M 0.07% 278

Other funds holding CVS

Concurrent Investment Advisors's CVS Position: Q1 2026 in Review

Concurrent Investment Advisors increased its CVS Health (CVS) stake by 39% in Q1 2026, buying an estimated $654K and bringing the position to 30,331 shares worth $2.18M. The position accounts for 0.02% of the portfolio, ranked #585.

Concurrent Investment Advisors first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.82M in Q3 2024. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Concurrent Investment Advisors held 30,331 shares of CVS Health worth $2.18M as of Q1 2026.
  • Concurrent Investment Advisors bought 8,491 CVS Health shares in Q1 2026, an estimated $654K.
  • CVS Health made up 0.02% of Concurrent Investment Advisors's portfolio in Q1 2026, its #585 holding.
  • Concurrent Investment Advisors first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's CVS Health position peaked at $3.82M in Q3 2024.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.